Major scientific discoveries can arise from simple decisions: say, by simply looking where virtually no one else has. Such ...

BACKGROUND: High-volume physical activity (PA) is associated with a higher prevalence of subclinical coronary artery disease ...

UPDATE: Mercedes-Benz SA has confirmed to Cars.co.za that no changes have been made to its vehicles’ equipment levels. The German firm’s local division told us it had “found efficiencies” through “its ...

And there’s at least a fair chance the diminutive hatchback will launch as Mzansi’s cheapest EV. BYD Auto SA confirmed to Cars.co.za that the “Seagull will be here later this year”, though added that ...

Quitting smoking is also critical, as smoking greatly increases the risk of aortic conditions like aneurysms. The aorta is the largest artery in the body to which all other major arteries are ...

Struggling SA farmers say a $55 million drought package offers a vital boost—but one old cocky warns the mental health cracks are starting to show. The package builds on an $18m plan revealed in ...

One way to promote healthy arteries is through the use of artery cleanse supplements. These supplements are designed to help remove plaque buildup in the arteries and improve blood flow.

Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of acute coronary syndrome or sudden cardiac death, primarily affecting relatively young women (median age, 51 years) ...

Here we use genetically predicted reaction fluxes to perform a systematic search for metabolic fluxes acting as buffers or amplifiers of coronary artery disease (CAD) risk alleles. Our analysis ...

There is no easy way to unclog an artery once plaque has built up. However, dietary choices, exercise, and avoiding smoking can improve cardiovascular health and stop blockages from worsening.

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated ...

The HOST-BR trial demonstrated that for patients at either high or low risk of bleeding, 3 months is the optimal duration of treatment to reduce adverse events without increasing bleeding risk ...